Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus

Aims To assess the relationship of longitudinal changes in fat mass (FM), lean mass (LM) and waist circumference (WC) with incident kidney outcomes in people with overweight/obesity and type 2 diabetes mellitus (T2DM). Materials and Methods A total of 3927 participants with baseline estimated glomer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes, obesity & metabolism obesity & metabolism, 2024-09, Vol.26 (9), p.3597-3605
Hauptverfasser: Zu, Cheng, Liu, Mengyi, Wang, Gangling, Meng, Qiguo, Gan, Xiaoqin, He, Panpan, Zhou, Chun, Ye, Ziliang, Wei, Yuanxiu, Su, Xinyue, Zhang, Yuanyuan, Qin, Xianhui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3605
container_issue 9
container_start_page 3597
container_title Diabetes, obesity & metabolism
container_volume 26
creator Zu, Cheng
Liu, Mengyi
Wang, Gangling
Meng, Qiguo
Gan, Xiaoqin
He, Panpan
Zhou, Chun
Ye, Ziliang
Wei, Yuanxiu
Su, Xinyue
Zhang, Yuanyuan
Qin, Xianhui
description Aims To assess the relationship of longitudinal changes in fat mass (FM), lean mass (LM) and waist circumference (WC) with incident kidney outcomes in people with overweight/obesity and type 2 diabetes mellitus (T2DM). Materials and Methods A total of 3927 participants with baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 from the Look AHEAD (Action for Health in Diabetes) trial were included. The primary outcome was kidney outcomes, defined as a decrease in eGFR of at least 40% from baseline at follow‐up visit, or end‐stage kidney disease. Results During a median follow‐up of 8.0 years, 450 kidney outcomes were documented after the first 1 year. In the intensive lifestyle intervention (ILI) group, reductions in FM (per 10% decrease, adjusted hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.69–0.94) and WC (per 10% decrease, adjusted HR 0.72, 95% CI 0.59–0.88) from baseline to 1‐year follow‐up were significantly associated with a lower risk of kidney outcomes. The change in LM was not significantly associated with risk of kidney outcomes (per 10% decrease, adjusted HR 0.78, 95% CI 0.58–1.06). In the diabetes support and education group (control group), no significant association was found between changes in body composition and kidney outcomes. Similar results were observed for the 4‐year changes in body composition. Conclusions In this post hoc analysis of the Look AHEAD trial, longitudinal declines in FM and WC were associated with a lower risk of kidney outcomes in the ILI group in participants with overweight/obesity and T2DM.
doi_str_mv 10.1111/dom.15699
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3066338715</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3087919487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2439-c85160cc9ff511218cca819b8a8fccc1445dd61a0e5cf040de439f02d762ea273</originalsourceid><addsrcrecordid>eNp1kctO3DAUhq2qiMuURV-gstRNWYTxJRdniSi0lUCzoevIY5_MGBI7tR1GeRzeFM-EdlEJb2zJ3__p6PwIfabkkqaz1K6_pEVZ1x_QKc1LnlHOyo-HN8tETdgJOgvhkRCSc1EdoxMuRMErmp-il6sQnDIyGmfxGuIOwOLO2Y2JozZWdlhtpd1AwCb9Oz1h5frBBXMISKtx3AL2Jjxh1-Inoy1M2I0xUXNmkD4aZQZpY8A7E7fYPYPfgdls49KtIZmm2TMNgBnWRqYxUraHrktDhE_oqJVdgPO3e4F-3948XP_M7lY_fl1f3WWK5bzOlChoSZSq27aglFGhlBS0XgspWqUUzfNC65JKAoVqSU40pFRLmK5KBpJVfIG-zd7Buz8jhNj0Jqg0hLTgxtBwUpY8rY8WCf36H_roRp-WtadEVdM6F3vhxUwp70Lw0DaDN730U0NJs--tSb01h94S--XNOK570P_Iv0UlYDkDO9PB9L6p-b66n5Wv_wmlhg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3087919487</pqid></control><display><type>article</type><title>Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus</title><source>Access via Wiley Online Library</source><creator>Zu, Cheng ; Liu, Mengyi ; Wang, Gangling ; Meng, Qiguo ; Gan, Xiaoqin ; He, Panpan ; Zhou, Chun ; Ye, Ziliang ; Wei, Yuanxiu ; Su, Xinyue ; Zhang, Yuanyuan ; Qin, Xianhui</creator><creatorcontrib>Zu, Cheng ; Liu, Mengyi ; Wang, Gangling ; Meng, Qiguo ; Gan, Xiaoqin ; He, Panpan ; Zhou, Chun ; Ye, Ziliang ; Wei, Yuanxiu ; Su, Xinyue ; Zhang, Yuanyuan ; Qin, Xianhui</creatorcontrib><description>Aims To assess the relationship of longitudinal changes in fat mass (FM), lean mass (LM) and waist circumference (WC) with incident kidney outcomes in people with overweight/obesity and type 2 diabetes mellitus (T2DM). Materials and Methods A total of 3927 participants with baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 from the Look AHEAD (Action for Health in Diabetes) trial were included. The primary outcome was kidney outcomes, defined as a decrease in eGFR of at least 40% from baseline at follow‐up visit, or end‐stage kidney disease. Results During a median follow‐up of 8.0 years, 450 kidney outcomes were documented after the first 1 year. In the intensive lifestyle intervention (ILI) group, reductions in FM (per 10% decrease, adjusted hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.69–0.94) and WC (per 10% decrease, adjusted HR 0.72, 95% CI 0.59–0.88) from baseline to 1‐year follow‐up were significantly associated with a lower risk of kidney outcomes. The change in LM was not significantly associated with risk of kidney outcomes (per 10% decrease, adjusted HR 0.78, 95% CI 0.58–1.06). In the diabetes support and education group (control group), no significant association was found between changes in body composition and kidney outcomes. Similar results were observed for the 4‐year changes in body composition. Conclusions In this post hoc analysis of the Look AHEAD trial, longitudinal declines in FM and WC were associated with a lower risk of kidney outcomes in the ILI group in participants with overweight/obesity and T2DM.</description><identifier>ISSN: 1462-8902</identifier><identifier>ISSN: 1463-1326</identifier><identifier>EISSN: 1463-1326</identifier><identifier>DOI: 10.1111/dom.15699</identifier><identifier>PMID: 38853714</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Body composition ; Body fat ; Body measurements ; Body weight ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; diabetic nephropathy ; Epidermal growth factor receptors ; Glomerular filtration rate ; Kidney diseases ; Obesity ; Overweight ; type 2 diabetes ; weight control</subject><ispartof>Diabetes, obesity &amp; metabolism, 2024-09, Vol.26 (9), p.3597-3605</ispartof><rights>2024 John Wiley &amp; Sons Ltd.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2439-c85160cc9ff511218cca819b8a8fccc1445dd61a0e5cf040de439f02d762ea273</cites><orcidid>0000-0001-7812-7982</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdom.15699$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdom.15699$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38853714$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zu, Cheng</creatorcontrib><creatorcontrib>Liu, Mengyi</creatorcontrib><creatorcontrib>Wang, Gangling</creatorcontrib><creatorcontrib>Meng, Qiguo</creatorcontrib><creatorcontrib>Gan, Xiaoqin</creatorcontrib><creatorcontrib>He, Panpan</creatorcontrib><creatorcontrib>Zhou, Chun</creatorcontrib><creatorcontrib>Ye, Ziliang</creatorcontrib><creatorcontrib>Wei, Yuanxiu</creatorcontrib><creatorcontrib>Su, Xinyue</creatorcontrib><creatorcontrib>Zhang, Yuanyuan</creatorcontrib><creatorcontrib>Qin, Xianhui</creatorcontrib><title>Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus</title><title>Diabetes, obesity &amp; metabolism</title><addtitle>Diabetes Obes Metab</addtitle><description>Aims To assess the relationship of longitudinal changes in fat mass (FM), lean mass (LM) and waist circumference (WC) with incident kidney outcomes in people with overweight/obesity and type 2 diabetes mellitus (T2DM). Materials and Methods A total of 3927 participants with baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 from the Look AHEAD (Action for Health in Diabetes) trial were included. The primary outcome was kidney outcomes, defined as a decrease in eGFR of at least 40% from baseline at follow‐up visit, or end‐stage kidney disease. Results During a median follow‐up of 8.0 years, 450 kidney outcomes were documented after the first 1 year. In the intensive lifestyle intervention (ILI) group, reductions in FM (per 10% decrease, adjusted hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.69–0.94) and WC (per 10% decrease, adjusted HR 0.72, 95% CI 0.59–0.88) from baseline to 1‐year follow‐up were significantly associated with a lower risk of kidney outcomes. The change in LM was not significantly associated with risk of kidney outcomes (per 10% decrease, adjusted HR 0.78, 95% CI 0.58–1.06). In the diabetes support and education group (control group), no significant association was found between changes in body composition and kidney outcomes. Similar results were observed for the 4‐year changes in body composition. Conclusions In this post hoc analysis of the Look AHEAD trial, longitudinal declines in FM and WC were associated with a lower risk of kidney outcomes in the ILI group in participants with overweight/obesity and T2DM.</description><subject>Body composition</subject><subject>Body fat</subject><subject>Body measurements</subject><subject>Body weight</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>diabetic nephropathy</subject><subject>Epidermal growth factor receptors</subject><subject>Glomerular filtration rate</subject><subject>Kidney diseases</subject><subject>Obesity</subject><subject>Overweight</subject><subject>type 2 diabetes</subject><subject>weight control</subject><issn>1462-8902</issn><issn>1463-1326</issn><issn>1463-1326</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kctO3DAUhq2qiMuURV-gstRNWYTxJRdniSi0lUCzoevIY5_MGBI7tR1GeRzeFM-EdlEJb2zJ3__p6PwIfabkkqaz1K6_pEVZ1x_QKc1LnlHOyo-HN8tETdgJOgvhkRCSc1EdoxMuRMErmp-il6sQnDIyGmfxGuIOwOLO2Y2JozZWdlhtpd1AwCb9Oz1h5frBBXMISKtx3AL2Jjxh1-Inoy1M2I0xUXNmkD4aZQZpY8A7E7fYPYPfgdls49KtIZmm2TMNgBnWRqYxUraHrktDhE_oqJVdgPO3e4F-3948XP_M7lY_fl1f3WWK5bzOlChoSZSq27aglFGhlBS0XgspWqUUzfNC65JKAoVqSU40pFRLmK5KBpJVfIG-zd7Buz8jhNj0Jqg0hLTgxtBwUpY8rY8WCf36H_roRp-WtadEVdM6F3vhxUwp70Lw0DaDN730U0NJs--tSb01h94S--XNOK570P_Iv0UlYDkDO9PB9L6p-b66n5Wv_wmlhg</recordid><startdate>202409</startdate><enddate>202409</enddate><creator>Zu, Cheng</creator><creator>Liu, Mengyi</creator><creator>Wang, Gangling</creator><creator>Meng, Qiguo</creator><creator>Gan, Xiaoqin</creator><creator>He, Panpan</creator><creator>Zhou, Chun</creator><creator>Ye, Ziliang</creator><creator>Wei, Yuanxiu</creator><creator>Su, Xinyue</creator><creator>Zhang, Yuanyuan</creator><creator>Qin, Xianhui</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7812-7982</orcidid></search><sort><creationdate>202409</creationdate><title>Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus</title><author>Zu, Cheng ; Liu, Mengyi ; Wang, Gangling ; Meng, Qiguo ; Gan, Xiaoqin ; He, Panpan ; Zhou, Chun ; Ye, Ziliang ; Wei, Yuanxiu ; Su, Xinyue ; Zhang, Yuanyuan ; Qin, Xianhui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2439-c85160cc9ff511218cca819b8a8fccc1445dd61a0e5cf040de439f02d762ea273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Body composition</topic><topic>Body fat</topic><topic>Body measurements</topic><topic>Body weight</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>diabetic nephropathy</topic><topic>Epidermal growth factor receptors</topic><topic>Glomerular filtration rate</topic><topic>Kidney diseases</topic><topic>Obesity</topic><topic>Overweight</topic><topic>type 2 diabetes</topic><topic>weight control</topic><toplevel>online_resources</toplevel><creatorcontrib>Zu, Cheng</creatorcontrib><creatorcontrib>Liu, Mengyi</creatorcontrib><creatorcontrib>Wang, Gangling</creatorcontrib><creatorcontrib>Meng, Qiguo</creatorcontrib><creatorcontrib>Gan, Xiaoqin</creatorcontrib><creatorcontrib>He, Panpan</creatorcontrib><creatorcontrib>Zhou, Chun</creatorcontrib><creatorcontrib>Ye, Ziliang</creatorcontrib><creatorcontrib>Wei, Yuanxiu</creatorcontrib><creatorcontrib>Su, Xinyue</creatorcontrib><creatorcontrib>Zhang, Yuanyuan</creatorcontrib><creatorcontrib>Qin, Xianhui</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes, obesity &amp; metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zu, Cheng</au><au>Liu, Mengyi</au><au>Wang, Gangling</au><au>Meng, Qiguo</au><au>Gan, Xiaoqin</au><au>He, Panpan</au><au>Zhou, Chun</au><au>Ye, Ziliang</au><au>Wei, Yuanxiu</au><au>Su, Xinyue</au><au>Zhang, Yuanyuan</au><au>Qin, Xianhui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus</atitle><jtitle>Diabetes, obesity &amp; metabolism</jtitle><addtitle>Diabetes Obes Metab</addtitle><date>2024-09</date><risdate>2024</risdate><volume>26</volume><issue>9</issue><spage>3597</spage><epage>3605</epage><pages>3597-3605</pages><issn>1462-8902</issn><issn>1463-1326</issn><eissn>1463-1326</eissn><abstract>Aims To assess the relationship of longitudinal changes in fat mass (FM), lean mass (LM) and waist circumference (WC) with incident kidney outcomes in people with overweight/obesity and type 2 diabetes mellitus (T2DM). Materials and Methods A total of 3927 participants with baseline estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 from the Look AHEAD (Action for Health in Diabetes) trial were included. The primary outcome was kidney outcomes, defined as a decrease in eGFR of at least 40% from baseline at follow‐up visit, or end‐stage kidney disease. Results During a median follow‐up of 8.0 years, 450 kidney outcomes were documented after the first 1 year. In the intensive lifestyle intervention (ILI) group, reductions in FM (per 10% decrease, adjusted hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.69–0.94) and WC (per 10% decrease, adjusted HR 0.72, 95% CI 0.59–0.88) from baseline to 1‐year follow‐up were significantly associated with a lower risk of kidney outcomes. The change in LM was not significantly associated with risk of kidney outcomes (per 10% decrease, adjusted HR 0.78, 95% CI 0.58–1.06). In the diabetes support and education group (control group), no significant association was found between changes in body composition and kidney outcomes. Similar results were observed for the 4‐year changes in body composition. Conclusions In this post hoc analysis of the Look AHEAD trial, longitudinal declines in FM and WC were associated with a lower risk of kidney outcomes in the ILI group in participants with overweight/obesity and T2DM.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>38853714</pmid><doi>10.1111/dom.15699</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7812-7982</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1462-8902
ispartof Diabetes, obesity & metabolism, 2024-09, Vol.26 (9), p.3597-3605
issn 1462-8902
1463-1326
1463-1326
language eng
recordid cdi_proquest_miscellaneous_3066338715
source Access via Wiley Online Library
subjects Body composition
Body fat
Body measurements
Body weight
Diabetes
Diabetes mellitus (non-insulin dependent)
diabetic nephropathy
Epidermal growth factor receptors
Glomerular filtration rate
Kidney diseases
Obesity
Overweight
type 2 diabetes
weight control
title Association between longitudinal changes in body composition and the risk of kidney outcomes in participants with overweight/obesity and type 2 diabetes mellitus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A34%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20between%20longitudinal%20changes%20in%20body%20composition%20and%20the%20risk%20of%20kidney%20outcomes%20in%20participants%20with%20overweight/obesity%20and%20type%202%20diabetes%20mellitus&rft.jtitle=Diabetes,%20obesity%20&%20metabolism&rft.au=Zu,%20Cheng&rft.date=2024-09&rft.volume=26&rft.issue=9&rft.spage=3597&rft.epage=3605&rft.pages=3597-3605&rft.issn=1462-8902&rft.eissn=1463-1326&rft_id=info:doi/10.1111/dom.15699&rft_dat=%3Cproquest_cross%3E3087919487%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3087919487&rft_id=info:pmid/38853714&rfr_iscdi=true